LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 94 of 166
Next
>>
>
2326 to 2350 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	NU7441	1.11	uM	LJP5	72	hr	1097	3731	3846	0.9710	0.9680
BT-20	NU7441	3.33	uM	LJP5	72	hr	1097	3048	3846	0.7929	0.7587
BT-20	NU7441	10	uM	LJP5	72	hr	1097	1317	3846	0.3417	0.1029
BT-20	OSI-027	0.04	uM	LJP6	72	hr	1097	3523	3673	0.9593	0.9513
BT-20	OSI-027	0.12	uM	LJP6	72	hr	1097	2885	3673	0.7856	0.7411
BT-20	OSI-027	0.37	uM	LJP6	72	hr	1097	2380	3673	0.6481	0.5592
BT-20	OSI-027	1.11	uM	LJP6	72	hr	1097	2102	3673	0.5727	0.4517
BT-20	OSI-027	3.33	uM	LJP6	72	hr	1097	1671	3673	0.4548	0.2723
BT-20	OSI-027	10	uM	LJP6	72	hr	1097	1275	3673	0.3473	0.0898
BT-20	WYE-125132	0.04	uM	LJP6	72	hr	1097	1767	3673	0.4811	0.3144
BT-20	WYE-125132	0.12	uM	LJP6	72	hr	1097	1399	3673	0.3809	0.1495
BT-20	WYE-125132	0.37	uM	LJP6	72	hr	1097	1319	3673	0.3592	0.1115
BT-20	WYE-125132	1.11	uM	LJP6	72	hr	1097	1252	3673	0.3407	0.0770
BT-20	WYE-125132	3.33	uM	LJP6	72	hr	1097	1166	3673	0.3176	0.0356
BT-20	WYE-125132	10	uM	LJP6	72	hr	1097	1009	3673	0.2747	-0.0472
BT-20	Barasertib	0.04	uM	LJP5	72	hr	1097	2918	3846	0.7576	0.7134
BT-20	Barasertib	0.12	uM	LJP5	72	hr	1097	2171	3846	0.5641	0.4525
BT-20	Barasertib	0.37	uM	LJP5	72	hr	1097	2041	3846	0.5303	0.4074
BT-20	Barasertib	1.11	uM	LJP5	72	hr	1097	1795	3846	0.4664	0.3112
BT-20	Barasertib	3.33	uM	LJP5	72	hr	1097	1512	3846	0.3933	0.1938
BT-20	Barasertib	10	uM	LJP5	72	hr	1097	1145	3846	0.2987	0.0231
BT-20	Vemurafenib	0.04	uM	LJP5	72	hr	1097	3679	3846	0.9572	0.9522
BT-20	Vemurafenib	0.12	uM	LJP5	72	hr	1097	3676	3846	0.9564	0.9516
BT-20	Vemurafenib	0.37	uM	LJP5	72	hr	1097	3582	3846	0.9322	0.9241
BT-20	Vemurafenib	1.11	uM	LJP5	72	hr	1097	3454	3846	0.8980	0.8843

|<
<<
Previous
Page 94 of 166
Next
>>
>
2326 to 2350 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)